Navigation Links
New discovery proves cause of weight problems in Huntington's disease
Date:4/6/2011

The study, which has been published in the scientific journal Cell Metabolism, shows significant changes in the brain's hormone control centre, the hypothalamus. In a series of experiments on mice, which had the mutated Huntington's protein injected into this area of their brains, the animals soon demonstrated a reduced ability to regulate their metabolism.

"With the selectively produced mutated protein, we saw immediate changes; the mice started to eat more and became very fat. We have now been able to prove that there is a causal relationship between this mutated protein in the hypothalamus and weight gain. The changes we see in the mice's brains are similar to those we have previously observed in the brains of Huntington's patients", says doctor and researcher sa Petersn at Lund University.

The effects of the mutated Huntington's protein disable the normal control of blood sugar levels in the body. It is probable that a resistance to insulin is developed, which makes some nerve cells deaf to important signals. This stops the complex metabolic system working.

The research group has previously shown that the pathological changes in the hypothalamus begin up to ten years before the movement problems are seen. This means that new treatments targeted at the small communications control centre, the hypothalamus, could provide relief to Huntington's patients at a much earlier stage.

One of the most promising treatments that are currently being researched aims to 'turn off' the mutated Huntington's gene. The research group in Lund has successfully tested the method on mice, with the result that they stopped developing irregularities in their metabolism.

"Our idea is to turn off the mutated gene in the hypothalamus. The problem is that we don't want to turn off the normal Huntingtin gene, which still has an important function. We now hope to be able to refine our method and focus specifically on the mutated Huntingtin", says sa Petersn.

The newly discovered changes in the hypothalamus in Huntington's disease are a growing research field. The targets for new treatments are non-motor symptoms such as weight problems, sleeping problems and depression.


'/>"/>

Contact: sa Petersen
Asa.Petersen@med.lu.se
46-709-422-930
Lund University
Source:Eurekalert

Related medicine news :

1. UCSF Enters Drug Discovery Agreement with Genentech
2. UCSF enters drug discovery agreement with Genentech
3. New discovery: Plaice are spotted (on the inside)
4. SeqWright Advances Genomic Discovery With Isilon IQ
5. Effective prostate cancer treatment discovery
6. Co-Creator of Six Sigma Unveils “The Great Discovery” ... the 4th Generation of Six Sigma
7. U discovery gives insight into brain replay process
8. Discovery of cellular switch may provide new means of triggering cell death, treating disease
9. Discovery May Lead to Better Multiple Sclerosis Treatments
10. Astrogenetix Narrows in on MRSA Virulence Onboard Discovery
11. TGen Drug Development partners with Horizon Discovery for integrated personalized medicine service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
Breaking Medicine Technology: